2010, Number 1
Aminopterin/methotrexate syndrome in an infant: a neurosurgical perspective
Lemus-Rodríguez Y, Morán-Martínez RG, Santana-Ramírez A
Language: Spanish
References: 7
Page: 28-32
PDF size: 534.94 Kb.
ABSTRACT
Infant 1 year and 11 months old with severe macrocephaly secondary to hydrocephalus and dysmorphic syndrome by computed tomography (CT) revealed holoprosencefaly, hydrocephalus, agenesis of corpus callosum and absence of shell. The mother had history of taking methotrexate during the first trimester of pregnancy, taking this in consideration, so aminopterin/methotrexate syndrome is diagnosed. A ventricular peritoneal shunt (VP shunt) was installed and subsequently several surgical craneoplasties were performed, achieving a reconstruction of the frontal skull and a decrease of temporal bumps was made using bone grafting in occipitoparietal region, which resulted in benefical changes in the patient's neurological development. Aminopterin/methotrexate syndrome is found in children from women who take acid folic antagonist during pregnancy. It is characterized by defects in neural tube closure. The mainly afected weeks are between six and eigth post conception. Methotrexate is classificated as an X drug by FDA and it must be not prescribed during pregnancy. Because the low incidence of this syndrome, it is important to report the case and the treatment response, as well the interdisciplinary work that it requires.REFERENCES